5th Annual Biotech Financing Symposium

Critical concerns to be addressed include:

State of the Biotech Industry: Where is it going?
Biotech Investing: What do Investors Look For In Their Investments?
Crossing the Chasm: Moving from Early Stage to Later Stage Companies
Creative Ways for Biotech Companies to Raise Funding
Strategic Alliances, Partnering, Licensing and Outsourcing
Translating Science into A Business Reality
Accessing the Public Market in Today's Environment
Post IPO Analysis from Wall Street Analysts and Portfolio Managers
Convergence of Biological Sciences and IT
Investment opportunities in RNAI and Cancer Treatment
Case Study: What It Takes To Have A Successful Merger: The CEO's Perspective
Getting Through the Clinical Trials In Most Efficient Ways

and over 40 speakers including industry leaders from:

A.M. Pappas & Associates
Acologix Inc.
Acorda Therapeutics
Avanir Pharmaceuticals
BIOMEDICAL INSIGHTS, INC.
California Technology Ventures
Cordova Ventures
Entelos
FasterCures
Food & Drug Administration
Forward Ventures
Hamilton Apex Ventures
Idenix Pharmaceuticals, Inc.
LSIT Global Institute
Mayer, Brown, Rowe & Maw
MEDICAL DISCOVERIES INC.
Merriman Curhan Ford & Co.
Montgomery & Co., LLC
Nestle Ventures
Novartis
Paradigm Genetics, Inc.
Pfizer
ProSanos Corporation
Recombinant Capital Inc.
Robarts Research Institute
Salk Institute for Biological Studies
San Diego Regional Technology Alliance
San Diego Supercomputer Center
San Diego Tech Coast Angels
Science Futures Inc.
TargeGen Inc.
The Translational Genomics Research Institute
ThinkEquity Partners
Ventana Capital Management